0001231977-12-000075.txt : 20121102 0001231977-12-000075.hdr.sgml : 20121102 20121102160937 ACCESSION NUMBER: 0001231977-12-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121031 FILED AS OF DATE: 20121102 DATE AS OF CHANGE: 20121102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LEONARD CENTRAL INDEX KEY: 0001231949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 121176904 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-10-31 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231949 BELL LEONARD C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 CEO Common Stock, par value $.0001 per share 2012-10-31 4 M 0 5315 4.03 A 1687149 D Common Stock, par value $.0001 per share 2012-10-31 4 S 0 5315 95 D 1681834 D Common Stock, par value $.0001 per share 2012-10-31 4 S 0 2667 94.98 D 1679167 D Option to Purchase Common Stock 4.03 2012-10-31 4 M 0 2022 0 D 2004-12-08 2014-09-08 Common Stock, par value $.0001 per share 2022 0 D Option to Purchase Common Stock 4.03 2012-10-31 4 M 0 3293 0 D 2004-12-08 2014-09-08 Common Stock, par value $.0001 per share 3293 13515 D The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $94.90 - $95.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Leonard Bell 2012-11-02